Vicarious Surgical Inc. Shareholders Approve Reverse Stock Split Proposal

Key Points:

• Vicarious Surgical Inc. (the “Company”) held a special meeting of stockholders on April 8, 2026.
• Shareholders voted to approve an amendment to the Company’s Certificate of Incorporation to effect a reverse stock split of its Class A and Class B common stock.
• The reverse stock split ratio will be determined by the Board and can be within the range of 1-for-2 to 1-for-30.
• Quorum was met with approximately 60.68% of outstanding shares represented at the meeting.
• The decision gives the Board flexibility to implement the reverse split at their discretion.

Details for Investors:

On April 8, 2026, Vicarious Surgical Inc. convened a special meeting of stockholders for the primary purpose of voting on a critical proposal: to approve and adopt an amendment to the Company’s Certificate of Incorporation enabling a reverse stock split of all outstanding shares of Class A common stock and Class B common stock. The approved reverse split can be in a ratio ranging from 1-for-2 up to 1-for-30, with the exact ratio to be decided by the Company’s Board of Directors at a future date.

A total of 1,885,434 shares of Class A and Class B common stock were present or represented by proxy at the meeting, representing roughly 60.68% of the Company’s outstanding voting power. This attendance met the quorum required for conducting official business.

What is a Reverse Stock Split?
A reverse stock split reduces the number of outstanding shares while proportionally increasing the per-share price. For example, in a 1-for-10 split, every 10 shares would be consolidated into 1 share, and the price would increase tenfold, though the total value of a shareholder’s holdings remains the same (excluding market effects). This is typically done to meet minimum price requirements for stock exchange listings or to make the stock more attractive to institutional investors.

Potential Price-Sensitive Implications:

• Share Price Impact: Reverse splits often increase the trading price of a company’s shares. This can help the Company comply with minimum price requirements for continued listing on exchanges, potentially reducing the risk of delisting. It can also attract new types of investors who may have policies against buying low-priced stocks.
• Market Perception: While a reverse split itself does not change the total value of the company, it can be perceived by the market as a signal that the company is taking action to address a depressed share price, which may be interpreted either positively or negatively by investors.
• Future Dilution Risk: Shareholders should be aware that while the reverse split does not itself dilute their ownership, it can sometimes be a precursor to other corporate actions such as capital raises.

Other Important Shareholder Information:

• The exact ratio and timing of the reverse split will be determined by the Board at a later date, giving flexibility to respond to market conditions.
• No other proposals were put to a vote at this special meeting.
• The company continues to qualify as an “emerging growth company” under applicable SEC rules.

Management Sign-Off:
The 8-K was signed by Stephen From, Chief Executive Officer, on April 8, 2026.

Disclaimer: The above article is based on recent SEC filings by Vicarious Surgical Inc. and is intended for informational purposes only. It does not constitute investment advice. Investors should conduct their own due diligence and consult with a financial advisor before making investment decisions. The Board has discretion on the reverse split ratio and timing; actual outcomes may differ from current expectations.

View Vicarious Surgical Inc. Historical chart here